APPLICATION
NDA217389
TYPE
NDA
ORIGINAL APPROVAL
2024-06-26
LATEST ACTION
2024-06-26
ROUTE
RESPIRATORY (INHALATION), INHALATION
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Prescription
Products
OHTUVAYRE · ReferencePrescription
ENSIFENTRINE 3MG/2.5ML · SUSPENSION · INHALATION
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.